News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
473,731 Results
Type
Article (25001)
Company Profile (159)
Press Release (448564)
Multimedia
Podcasts (46)
Webinars (14)
Section
Business (123905)
Career Advice (451)
Deals (20400)
Drug Delivery (52)
Drug Development (79414)
Employer Resources (44)
FDA (12704)
Job Trends (9323)
News (233582)
Policy (18689)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Standard (1)
2027 Pharm Country Standard (1)
Academia (1695)
Academic (1)
Accelerated approval (27)
Adcomms (29)
Allergies (131)
Alliances (33748)
ALS (170)
Alzheimer's disease (1630)
Antibody-drug conjugate (ADC) (301)
Approvals (13000)
Artificial intelligence (449)
Autoimmune disease (144)
Automation (27)
Bankruptcy (146)
Best Places to Work (8155)
BIOSECURE Act (12)
Biosimilars (132)
Biotechnology (119)
Bladder cancer (153)
Brain cancer (57)
Breast cancer (624)
Cancer (4627)
Cardiovascular disease (371)
Career advice (405)
Career pathing (19)
CAR-T (270)
CDC (11)
Celiac Disease (2)
Cell therapy (684)
Cervical cancer (36)
Clinical research (69357)
Collaboration (1449)
Company closure (3)
Compensation (842)
Complete response letters (43)
COVID-19 (2136)
CRISPR (71)
C-suite (693)
Cystic fibrosis (136)
Data (6063)
Decentralized trials (2)
Denatured (21)
Depression (134)
Diabetes (420)
Diagnostics (5393)
Digital health (34)
Diversity (11)
Diversity, equity & inclusion (17)
Drug discovery (198)
Drug pricing (47)
Drug shortages (12)
Duchenne muscular dystrophy (196)
Earnings (50220)
Editorial (24)
Employer branding (3)
Employer resources (43)
Events (77349)
Executive appointments (796)
FDA (15512)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (10)
Frontotemporal dementia (21)
Funding (1250)
Gene editing (167)
Generative AI (39)
Gene therapy (519)
GLP-1 (723)
Government (2338)
Grass and pollen (6)
Guidances (299)
Healthcare (13766)
HIV (45)
Huntington's disease (47)
IgA nephropathy (81)
Immunology and inflammation (213)
Immuno-oncology (48)
Indications (98)
Infectious disease (2340)
Inflammatory bowel disease (189)
Inflation Reduction Act (4)
Influenza (95)
Intellectual property (205)
Interviews (63)
IPO (10997)
IRA (13)
Job creations (1494)
Job search strategy (351)
JPM (29)
Kidney cancer (16)
Labor market (36)
Layoffs (326)
Leadership (16)
Legal (2299)
Liver cancer (82)
Longevity (13)
Lung cancer (624)
Lymphoma (357)
Machine learning (31)
Management (14)
Manufacturing (499)
MASH (156)
Medical device (9535)
Medtech (9577)
Mergers & acquisitions (10277)
Metabolic disorders (1012)
Multiple sclerosis (150)
NASH (14)
Neurodegenerative disease (303)
Neuropsychiatric disorders (79)
Neuroscience (2780)
Neurotech (1)
NextGen: Class of 2026 (3879)
Non-profit (2428)
Now hiring (37)
Obesity (417)
Opinion (180)
Ovarian cancer (159)
Pain (189)
Pancreatic cancer (220)
Parkinson's disease (273)
Partnered (24)
Patents (391)
Patient recruitment (486)
Peanut (52)
People (38737)
Pharmaceutical (36)
Pharmacy benefit managers (7)
Phase 1 (22342)
Phase 2 (30877)
Phase 3 (22371)
Pipeline (4671)
Policy (99)
Postmarket research (2054)
Preclinical (8054)
Press Release (28)
Prostate cancer (225)
Psychedelics (40)
Radiopharmaceuticals (271)
Rare diseases (744)
Real estate (2913)
Recruiting (17)
Regulatory (17762)
Reports (26)
Research institute (1884)
Resumes & cover letters (60)
Rett syndrome (27)
RNA editing (13)
RSV (48)
Schizophrenia (134)
Series A (222)
Series B (179)
Service/supplier (8)
Sickle cell disease (80)
Special edition (14)
Spinal muscular atrophy (151)
Sponsored (27)
Startups (2410)
State (1)
Stomach cancer (15)
Supply chain (51)
Tariffs (15)
The Weekly (25)
Vaccines (690)
Venture capital (55)
Weight loss (232)
Women's health (74)
Worklife (6)
Date
Today (9)
Last 7 days (495)
Last 30 days (1859)
Last 365 days (25491)
2026 (2380)
2025 (25740)
2024 (29269)
2023 (33132)
2022 (41019)
2021 (42973)
2020 (39530)
2019 (30527)
2018 (22971)
2017 (23778)
2016 (21705)
2015 (25405)
2014 (18364)
2013 (13799)
2012 (14427)
2011 (14803)
2010 (13940)
Location
Africa (373)
Alabama (73)
Alaska (3)
Arizona (172)
Arkansas (8)
Asia (28978)
Australia (5639)
California (9765)
Canada (2488)
China (1010)
Colorado (391)
Connecticut (400)
Delaware (276)
Europe (66246)
Florida (1345)
Georgia (305)
Hawaii (2)
Idaho (41)
Illinois (573)
India (41)
Indiana (402)
Iowa (17)
Japan (374)
Kansas (98)
Kentucky (33)
Louisiana (18)
Maine (27)
Maryland (1043)
Massachusetts (6941)
Michigan (198)
Minnesota (409)
Mississippi (4)
Missouri (92)
Montana (30)
Nebraska (17)
Nevada (102)
New Hampshire (64)
New Jersey (2456)
New Mexico (23)
New York (2563)
North Carolina (1202)
North Dakota (6)
Northern California (4803)
Ohio (253)
Oklahoma (20)
Oregon (36)
Pennsylvania (1886)
Puerto Rico (14)
Rhode Island (24)
South America (488)
South Carolina (43)
Southern California (3853)
Tennessee (132)
Texas (1568)
United States (33267)
Utah (262)
Vermont (1)
Virginia (214)
Washington D.C. (54)
Washington State (777)
West Virginia (2)
Wisconsin (80)
Wyoming (1)
473,731 Results for "clinical ink.rss".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Siren Biotechnology to Showcase Clinical-Stage Momentum at Major 2026 Healthcare Conferences
January 8, 2026
·
2 min read
Press Releases
TRexBio Closes $50 Million Financing to Support a Growing Clinical-Stage Immunology Pipeline of Tissue-Targeted Treg Therapeutics
January 27, 2026
·
4 min read
China
Clinical Trials Are Increasingly Going Global—With China a Main Beneficiary
AstraZeneca’s $15 billion pledge to its China operations highlights the country’s advantages. But other regions are also hoping to host more clinical studies.
February 2, 2026
·
8 min read
·
Annalee Armstrong
Press Releases
Crown Bioscience San Diego Laboratory Achieves CAP Accreditation, Building on CLIA Certification to Expand Clinical-Grade Capabilities
January 20, 2026
·
3 min read
Press Releases
Pluri and Remedy Cell Expand Collaboration; Successful Engineering Runs and Clinical-Grade Manufacturing Achieved
December 23, 2025
·
7 min read
Press Releases
Theralase(R) Provides Update on Bladder Cancer Clinical Study
Interim clinical data has exceeded the recommended guidelines of the International Bladder Cancer Group for complete response and duration of complete response
February 4, 2026
·
7 min read
Clinical research
5 Clinical Readouts to Watch in H1 2026
As 2026 begins, a slate of high-stakes clinical readouts—from a pivotal study of Novartis’ cardiovascular candidate pelacarsen to a Phase III test of Eli Lilly’s next-gen Alzheimer’s drug—are poised to reshape therapeutic landscapes.
January 5, 2026
·
7 min read
·
Ben Hargreaves
Press Releases
Windward Bio Expands Immunology Pipeline With WIN027, a Long-Acting, Clinical-Stage Bispecific Targeting TSLP and IL-13
December 22, 2025
·
4 min read
Press Releases
Precision BioSciences Sets Strategic Priorities for 2026 Focused on Continued Advancement of Clinical-Stage Programs PBGENE-HBV for Chronic Hepatitis B and PBGENE-DMD for Duchenne Muscular Dystrophy
January 12, 2026
·
11 min read
Press Releases
Palvella Therapeutics Provides Corporate Update and 2026 Outlook: Advancing a Late Clinical-Stage Pipeline and Platform to Address Multiple Serious, Rare Skin Diseases and Vascular Malformations with No FDA-Approved Therapies
January 9, 2026
·
14 min read
1 of 47,374
Next
